Gemigliptin – A Potential Treatment for Type 2 Diabetes
Gemigliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor developed by CKD Pharmaceuticals for the treatment of type 2 diabetes. DPP-4 is an enzyme responsible for the …
Empowering Industries, Enlightening Minds
Gemigliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor developed by CKD Pharmaceuticals for the treatment of type 2 diabetes. DPP-4 is an enzyme responsible for the …